Open Access

Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience

Jan Juřica

Jan Juřica

  • Faculty of Medicine, Department of Pharmacology, Masaryk UniversityBrno, Czech Republic
  • Masaryk Memorial Cancer InstituteBrno, Czech Republic
  • Faculty of Pharmacy, Department of Pharmacology and Toxicology, Masaryk UniversityBrno, Czech Republic
Search for this author on
Sciendo|Google Scholar
Juřica, Jan
, 
Roman Goněc

Roman Goněc

Masaryk Memorial Cancer InstituteBrno, Czech Republic
Search for this author on
Sciendo|Google Scholar
Goněc, Roman
, 
Adela Bártová

Adela Bártová

Faculty of Medicine, Department of Pharmacology, Masaryk UniversityBrno, Czech Republic
Search for this author on
Sciendo|Google Scholar
Bártová, Adela
 and 
Jana Gregorová

Jana Gregorová

Faculty of Medicine, Department of Biochemistry, Masaryk UniversityBrno, Czech Republic
Search for this author on
Sciendo|Google Scholar
Gregorová, Jana
  
Jun 18, 2022
Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Short Communication
Published Online: Jun 18, 2022
Page range: 84 - 86
Received: Apr 25, 2022
Accepted: May 10, 2022
DOI: https://doi.org/10.2478/afpuc-2022-0006
Keywords
© 2022 Jan Juřica et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Khan S, Gerber DE. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review. Semin Cancer Biol. 2020;64,93–101. KhanS GerberDE Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review Semin Cancer Biol 2020 64 93 101 10.1016/j.semcancer.2019.06.012698044431330185 Search in Google Scholar

Wang PF, Chen Y, Song SY et al. Immune-related adverse events associated with anti-PD-1/PD-L1 treatment for malignancies: A meta-analysis. Front Pharmacol. 2017;8,730. WangPF ChenY SongSY Immune-related adverse events associated with anti-PD-1/PD-L1 treatment for malignancies: A meta-analysis Front Pharmacol 2017 8 730 10.3389/fphar.2017.00730565153029093678 Search in Google Scholar

Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Pharmacy, Pharmacy, other
Journal RSS Feed